Astragalin attenuates lipopolysaccharide-induced inflammatory responses by down-regulating NF-κB signaling pathway

Biochemical and Biophysical Research Communications

Volumn 419, Issue 2, 2012, Pages 256-261

  Soromou, Lanan Wassy ^a   Chen, Na ^a   Jiang, Lanxiang ^b   Huo, Meixia ^a   Wei, Miaomiao ^a   Chu, Xiao ^a   Millimouno, Faya Martin ^c   Feng, Haihua ^a   Sidime, Youssouf ^c   Deng, Xuming ^a  

^a JILIN UNIVERSITY   (China)

^b THE SECOND HOSPITAL OF JILIN UNIVERSITY   (China)

^c Department of Veterinary Medicine   (Guinea)

Author keywords

Acute lung injury; Astragalin; Cytokine; Endotoxemia; Inflammatory responses; Lipopolysaccharide

Indexed keywords

ASTRAGALIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; ENDOTOXEMIA; INFLAMMATION; LUNG INJURY; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SURVIVAL;

ACUTE LUNG INJURY; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DISEASE MODELS, ANIMAL; DOWN-REGULATION; ENDOTOXEMIA; KAEMPFEROLS; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED BALB C; NF-KAPPA B; PNEUMONIA, BACTERIAL; SIGNAL TRANSDUCTION;

MURINAE; MUS;

EID: 84858000366     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.02.005     Document Type: Article

References (24)

1. Feng Q., Ren Y., Wang Y., Ma H., Xu J., Zhou C., Yin Z., Luo L. Anti-inflammatory effect of SQC-beta-CD on lipopolysaccharide-induced acute lung injury. J. Ethnopharmacol. 2008, 118:51-58.
2. Shimazu R., Akashi S., Ogata H., Nagai Y., Fukudome K., Miyake K., Kimoto M. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med. 1999, 189:1777-1782.
3. Parrillo J.E., Parker M.M., Natanson C., Suffredini A.F., Danner R.L., Cunnion R.E., Ognibene F.P. Septic shock in humans: advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann. Intern. Med. 1990, 113:227-242.
4. Bone R.C. The sepsis syndrome: definition and general approach to management. Clin. Chest. Med. 1996, 17:175-181.
5. Astiz M.E., Rackow E.C. Septic shock. Lancet 1998, 351:1501-1505.
6. Iontcheva I., Amar S., Zawawi K.H., Kantarci A., Van Dyke T.E. Role for moesin in lipopolysaccharide-stimulated signal transduction. Infect. Immun. 2004, 72:2312-2320.
7. Dai Q., Zhang J., Pruett S.B. Ethanol alters cellular activation and CD14 partitioning in lipid rafts. Biochem. Biophys. Res. Commun. 2005, 332:37-42.
8. Zhou L.F., Zhu Y., Cui X.F., Xie W.P., Hu A.H., Yin K.S. Arsenic trioxide, a potent inhibitor of NF-κB, abrogates allergen-induced airway hyper-responsiveness and inflammation. Respir. Res. 2006, 7:146.
9. Chen Z., Zhang X., Chu X., Zhang X., Song K., Jiang Y., Yu L., Deng X. Preventive effects of valnemulin on lipopolysaccharide-induced acute lung injury in mice. Inflammation 2010, 33:306-314.
10. Xu C.Q., Liu B.J., Wu J.F., Xu Y.C., Duan X.H., Cao Y.X., Dong J.C. Icariin attenuates LPS-induced acute inflammatory responses: involvement of PI3K/Akt and NF-κB signaling pathway. Eur. J. Pharmacol. 2010, 638:128-133.
11. Kwak J.H., Won S.W., Kim T.J., Roh E., Kang H.Y., Lee H.W., Jung J.K., Hwang B.Y., Kim Y., Cho J., Lee H. Synthesis of chroman-2-carboxylic acid N-(substituted) phenylamides and their inhibitory effect on nuclear factor-kappaB (NF-kappaB) activation. Arch. Pharm. Res. 2008, 31:133-141.
12. Kim M.S., Kim S.H. Inhibitory effect of astragalin on expression of lipopolysaccharide-induced inflammatory mediators through NF-κB in macrophages. Arch. Pharm. Res. 2011, 34:2101-2107.
13. Lee H.B., Kim E.K., Park S.J., Bang S.G., Kim T.G., Chung D.W. Isolation and anti-inflammatory effect of astragalin synthesized by enzymatic hydrolysis of tea seed extract. J. Sci. Food Agric. 2011, 91:2315-2321.
14. Anuradha R., Krishnamoorthy P. Effect of astragalin on the activities of membrane bound enzymes on leadacetate toxicity in albino rats. J. Chem. Pharm. Res. 2011, 3:616-620.
15. W.W. Chao, Y.H. Kuo, S.L. Hsieh, B.F. Lin, Inhibitory effects of ethyl acetate extract of Andrographis paniculata on NF-{kappa} B trans-activation activity and LPS-induced acute inflammation in mice, Evid. Based Complement Alternat. Med. (2009) doi: [Epub ahead of print. doi:10.1093/ecam/nep120.
16. Shinozaki S., Inoue Y., Yang W., Fukaya M., Carter E.A., Yu Y.M., Fischman A., Tompkins R., Kaneki M. Farnesyl transferase inhibitor improved survival following endotoxin challenge in mice. Biochem. Biophys. Res. Commun. 2010, 391:1459-1464.
17. Kwak S.H., Choi J.I., Park J.T. Effects of propofol on endotoxin-induced acute lung injury in rabbit. J. Korean Med. Sci. 2004, 19:55-61.
18. Y. Lin, X. Zhu, W.Z. Yao, Y.L. Yang, L.T. A, L. Chen, Yohimbine protects against endotoxin-induced acute lung injury by blockade of alpha 2A adrenergic receptor in rats, Chin. Med. J. 124 (2011) 1069-1074.
19. Bhatia M., Moochhala S. Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. J. Pathol. 2004, 202:145-156.
20. Matthay M.A., Zimmerman G.A. Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management. Am. J. Respir. Cell Mol. Biol. 2005, 33:319-327.
21. Skotnicka B., Hassmann E. Proinflammatory and immunoregulatory cytokines in the middle ear effusions. Int. J. Pediatr. Otorhinolaryngol. 2008, 72:13-17.
22. Paladino J.D., Hotchkiss J.R., Rabb H. Acute kidney injury and lung dysfunction: a paradigm for remote organ effects of kidney disease?. Microvasc. Res. 2009, 77:8-12.
23. Hopkins S.J. The pathophysiological role of cytokines. Legal Medicine 2003, 5:45-57.
24. Phan H.H., Cho K., Sainz-Lyon K.S., Shin S., Greenhalgh D.G. CD14-dependent modulation of NF-κB alternative splicing in the lung after burn injury. Gene 2006, 371:121-129.